ANGO - AngioDynamics Inc

https://www.angiodynamics.com

Strong Sell Momentum: Bearish

Recent News

Why Is AngioDynamics Stock Trading Higher On Thursday? - AngioDynamics ( NASDAQ:ANGO )

Benzinga • 1 year, 5 months ago • score: 0.22

Thursday, the FDA granted 510 ( k ) clearance to AngioDynamics Inc's ANGO AlphaVac F1885 System for pulmonary embolism ( PE ) .

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

AngioDynamics, Inc. designs, manufactures and sells various medical, surgical and diagnostic devices for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company is headquartered in Latham, New York.

52W High

$13.50

52W Low

$5.83

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

0.64

Valuation

Rich

As of 2025-05-31 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

96.15

EV/EBITDA (<8 favorable)

227.99

EV/Revenue (<3 favorable)

1.36

P/S (TTM) (<3 favorable)

1.49

P/B (<3 favorable)

2.38

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

6.84%

Institutions (25–75% balanced)

93.83%

Shares Outstanding

40,633,900

Float

31,380,300

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-05-31 (Overview)

Revenue (TTM)

292,498,000

Gross Profit (TTM)

157,705,000

EPS (TTM)

-0.83

Profit Margin (>10% good)

-0.12%

Operating Margin (TTM) (higher better)

-0.05%

ROE (TTM) (>15% strong)

-0.18%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.13

Momentum

Bearish momentum

Value

0.5732

0.6155

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025